DEFINITION and DESCRIPTIONS
Lupus or SLE (Systememic Lupus Erythematosus) is a chronic, life-long,potentially fatal autoimmune disease. This disease is characterized by unpredictable exacerbations (flare-ups) and remissions. SLE is an autoimmune disease characterized by immune dysregulation resulting in the production of antinuclear antibodies (ANA), immune complexes and the activation of the complement system. SLE is a complex disorder affecting a younger population with many similarities of HIV infection in regards for multiple organ involvement, the potential of life-threatening episodes and the need for hi-tech monitoring. By definition, Lupus or SLE is a disease in which the body's immune system turns on itself. By turning on itself, the body prepares to fight an invisible invader and thus attacks itself. This systemic autoimmune disorder produces a chronic inflammatory disease affecting all organ systems. The etiology of SLE remains unknown. A genetic predisposition, sex hormones and triggers from the environment may likely result in the dis-ordered immune response that is seen in the disease.
CHARACTERISTICS, SIGNS AND SYMPTOMS>
There are many clinical features that might be presented leading to a diagnosis of Lupus or SLE. Some of these include the following:
HOW LUPUS IS DIAGNOSED
As you can see, Lupus can and does strike many different organs and involves many organ systems of the body.
Due to this involvement, Lupus is very difficult to diagnose and maybe mis-diagnosed for a length of time. Diagnosis is based on the following criteria of which 4 (four) of the 11 listed MUST be present. The criteria includes:
Other diagnostic tools:
LABORATORY FINDINGS:
TYPES OF SLE
Lupus or SLE has many different types or forms depending upon the organ system involved. Some forms include:
TREATMENT
The goals of treatment are:
A. Preventative Care:
The list of medications used in the treatment of Lupus/SLE are many and can include many that are viewed as chemotherapy in nature. These can include the following:
Medication dosages vary from 125 to 150 mgs. per day orally. Cytoxan can also be given at a much higher dose (1000mg) by IV each month. This is effective for severe kidney damage and also vasculitis.
Side effects of using medications to control SLE vary. The long-term use of steroids can include: cataracts, muscle weakness, premature arteriosclerosis, osteoporosis and bone problems. The relationship between dose, duration and the resulting side effects are usually seen. Higher doses over longer periods of time have the likely result of more side effects than a lower dose over a shorter period of time.
Side effects noted in use of anti-malarials include: ocular toxicities including corneal deposits and retinopathy.
Side effects seen in the use of immunosuppressive medications are: increased risks of developing lymphomas and leukemia, bladder cancer and other tumors. Serious decrease in blood counts accounts for many dosage adjustments and frequent monitoring of these blood counts are made during medication therapy. Use of Cytoxan may cause bleeding from the bladder, but this can be prevented with drinking large amounts of water.
The health status of patients with SLE can change not only with the disease activity but also from the resulting damage to the body from recurrent flareups. This can be seen in the development of deforming joints, end stage renal disease, mental status changes noted in the brain and involvement of the lungs, hearts and vascular system. Other developments can be due to the adverse effects of current treatment, as seen in: anemias, recurrent infections, obesity and bone disorders.
IS THERE A CURE OUT THERE?
As we have seen Lupus or SLE affects woman in many different ways. Although there is no current cure available, treatment for the most part, is to reduce the incidence of flare-ups and relapses, reduce the severity of side effects seen with medications and improved health status in general. The prognosis has greatly improved over the years and now patients with Lupus/SLE can expect a 80-90% survival rate over 10 years. This increase is due to the most part in the advancements seen in medical management of the disease...improved medications, more high-tech monitoring of patients and their disease, improved criteria for diagnostic evaluation and overall specialized care to patients with Lupus/SLE.
Preventative measures and Patient education about the disease can be seen as improving health status and allowing woman to take an active role in the plan of care. Information is widely available now from a number of sources and through the use of the internet, support groups, mailing lists and more have sprung up insuring each patient support and encouragement along the way.
LINKS TO OTHER SITES ON THE WEB
Lupus Articles
The Virtual Hospital: University of Iowa Family Practice..."SLE"
Pursuit:careers for persons with Disabilities
CNN Report on Lupus,Feb.19,1997
Lupus Clinical Overview
Some useful phone numbers for requesting information on Lupus/SLE are:
DISCLAIMER: This website is not intended to take the place of a health professional or health practioner. Any ideas discussed here MUST be discussed with your health care provider or health professional in advance.
© 1997robinhutchens@geocities.com1>